James M. DeTore
Nessuna posizione attualmente
Provenienza dei contatti di primo grado di James M. DeTore
| Entità | Tipo di entità | Settore Industriale | |
|---|---|---|---|
| Public Company | Pharmaceuticals: Major | 36 | |
| Public Company | Biotechnology | 11 | |
| Extinct | Biotechnology | 5 | |
Microbia, Inc.
 Microbia, Inc. Pharmaceuticals: MajorHealth Technology Microbia, Inc. engages in the development of microbial manufacturing technologies for the production of chemicals from renewable raw materials. The company is headquartered in DE.
1
| Subsidiary | Pharmaceuticals: Major | 1 |
Grafico delle società connesse in secondo grado
Relazione in diverse aziende
Società connesse a James M. DeTore tramite i suoi contatti personali
| Società | Settore | Persone collegate | Posizione principale |
|---|---|---|---|
Genzyme Corp.
 Genzyme Corp. Medical SpecialtiesHealth Technology Genzyme Corp. engages in development and manufacture of specialty therapeutic, surgical and diagnostic product. It serves in the areas of rare genetic diseases, multiple sclerosis, cardiovascular diseases and endocrinology. The company was founded on June 8, 1981 and is headquartered in Cambridge, MA. | Medical Specialties | Founder Corporate Officer/Principal General Counsel Director/Board Member General Counsel Corporate Officer/Principal Sales & Marketing Director of Finance/CFO | |
| CYCLERION THERAPEUTICS, INC. | Pharmaceuticals: Major | Director/Board Member Chairman Director/Board Member Director of Finance/CFO Chief Operating Officer Director/Board Member | |
| Bentley University | College/University | Undergraduate Degree Graduate Degree Undergraduate Degree Graduate Degree Undergraduate Degree | |
| VERTEX PHARMACEUTICALS INCORPORATED | Pharmaceuticals: Major | Comptroller/Controller/Auditor Public Communications Contact Director of Finance/CFO Corporate Officer/Principal Chief Tech/Sci/R&D Officer | |
| Harvard Medical School | College/University | Corporate Officer/Principal Doctorate Degree Corporate Officer/Principal Graduate Degree | |
Millennium Pharmaceuticals, Inc.
 Millennium Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Millennium Pharmaceuticals, Inc. operates as a biopharmaceutical company. Its products include Ninlaro and Velcade. The company was founded in 1993 and is headquartered in Cambridge, MA. | Pharmaceuticals: Major | Director of Finance/CFO Chief Tech/Sci/R&D Officer Investor Relations Contact Corporate Officer/Principal | |
| Dartmouth College | College/University | Doctorate Degree Undergraduate Degree Undergraduate Degree | |
| TCR2 THERAPEUTICS INC. | Pharmaceuticals: Major | Director/Board Member Director of Finance/CFO Chief Operating Officer | |
Harvard University
 Harvard University Other Consumer ServicesConsumer Services Harvard University engages in the provision of teaching and research. It has twelve degree-granting Schools in addition to the Radcliffe Institute for Advanced Study, offering a global education. The university was founded in 1636 and is headquartered in Cambridge, MA. | College/University | Undergraduate Degree Doctorate Degree Doctorate Degree | |
| BIOGEN INC. | Pharmaceuticals: Major | Director/Board Member Chief Tech/Sci/R&D Officer Corporate Officer/Principal | |
| Tufts University | College/University | Corporate Officer/Principal Undergraduate Degree Undergraduate Degree | |
Genesis Research & Development Corp. Ltd.
 Genesis Research & Development Corp. Ltd. Financial ConglomeratesFinance Genesis Research & Development Corp. Ltd. operates as a development stage company. Previously, it was a technology investment company that builds a broad therapeutic development platform targeting immune disorders and cancer and a novel single stranded gene silencing technology using the RNAi mechanism. The company was founded by James Douglas Watson in 1994 and is headquartered in Auckland, New Zealand. | Financial Conglomerates | Director/Board Member Corporate Officer/Principal | |
Third Rock Ventures LLC
 Third Rock Ventures LLC Investment ManagersFinance Third Rock Ventures LLC (Third Rock Ventures) is a venture capital firm founded in 2007 by Mark Levin, Robert Tepper, Kevin Starr and Nick Leschly. The firm is headquartered in Boston, Massachusetts. | Investment Managers | Private Equity Investor Corporate Officer/Principal | |
Genentech, Inc.
 Genentech, Inc. BiotechnologyHealth Technology Genentech, Inc. develops, manufactures and markets pharmaceutical products for life-threatening medical conditions. It studies various areas including oncology, immunology, neuroscience, ophthalmic diseases, microbial pathogenesis, metabolic diseases, cardiovascular diseases, and opportunistic areas. The company was founded by Herb W. Boyer and Robert A. Swanson in 1976 and is headquartered in South San Francisco, CA. | Biotechnology | Director of Finance/CFO Corporate Officer/Principal | |
| ARCUTIS BIOTHERAPEUTICS, INC. | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
| STEALTH BIOTHERAPEUTICS CORP | Biotechnology | Director/Board Member Human Resources Officer | |
Rapport Therapeutics, Inc.
 Rapport Therapeutics, Inc. BiotechnologyHealth Technology Rapport Therapeutics, Inc. engages in the discovery and development of transformational small molecule medicines for patients suffering from central nervous system disorders. It develops the RAP (receptor associated proteins) technology platform. The company was founded by Steven M. Paul and David Bredt in February 2022 and is headquartered in Boston, MA. | Biotechnology | Chief Executive Officer Chief Operating Officer | |
Polaris Growth Management LLC
 Polaris Growth Management LLC Investment ManagersFinance Polaris Partners is an Independent Venture Capital firm founded in 1996 by Stephen D. Arnold, Jonathan A. Flint and Terrance G. McGuire. Polaris Partners is headquartered in Waltham. | Investment Managers | Private Equity Investor Director/Board Member | |
Pulmatrix Operating Co., Inc.
 Pulmatrix Operating Co., Inc. Pharmaceuticals: MajorHealth Technology Pulmatrix Operating Co., Inc. develops pharmaceutical products for respiratory infectious diseases. Its iSPERSE powders can be used with an array of dry powder inhaler technologies and can be formulated with virtually any drug substance. The company was founded by David Alan Edwards, Mark J. Gabrielson, Alexander M. Klibanov and Robert S. Langer in 2003 and is headquartered in Lexington, MA. | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
Arthur D. Little, Inc.
 Arthur D. Little, Inc. Miscellaneous Commercial ServicesCommercial Services Arthur D. Little, Inc. engages in the provision of management consulting services. It specializes in strategy and organization, operations management, technology and innovation management, corporate finance, and global carbon advisory serving corporations and organizations worldwide. The firm serves the automotive, healthcare, information, chemicals, consumer goods, retail, manufacturing, and transportation industries. The company was founded by Arthur Dehon Little and Roger Griffin in October 1886 and is headquartered in Boston, MA. | Miscellaneous Commercial Services | Director/Board Member Corporate Officer/Principal | |
| JOHNSON & JOHNSON | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal | |
| EDITAS MEDICINE, INC. | Biotechnology | Corporate Officer/Principal Director of Finance/CFO | |
| St. Joseph's University | College/University | Masters Business Admin Masters Business Admin | |
Alliance for Regenerative Medicine
 Alliance for Regenerative Medicine Medical/Nursing ServicesHealth Services ARM is a Washington, DC-based multi-stakeholder advocacy organization that promotes global initiatives necessary to facilitate access to life-giving advances in regenerative medicine. The organization promotes legislative, regulatory reimbursement, investment, technical, and other initiatives to accelerate the development of safe and effective regenerative medicine technologies. ARM also works to increase public understand- ing of the field and its potential to transform human healthcare. Prior to the formation of ARM in 2009, there was a need for more coordinated and cohesive advocacy representing the interests of the companies, research institutions, investors and patient groups that comprise the entire regenerative medicine community. Today ARM has more than 140 members and is the leading global advocacy organization in this field. | Medical/Nursing Services | Director/Board Member Director/Board Member | |
| VERASTEM, INC. | Biotechnology | Director/Board Member Director/Board Member | |
| TAKEDA PHARMACEUTICAL COMPANY LIMITED | Pharmaceuticals: Major | Director of Finance/CFO Director/Board Member | |
| University of California, Berkeley | College/University | Graduate Degree Undergraduate Degree | |
| Princeton University | College/University | Undergraduate Degree Doctorate Degree | |
Semma Therapeutics, Inc.
 Semma Therapeutics, Inc. BiotechnologyHealth Technology Semma Therapeutics, Inc. develops transformative therapies for patients who currently depend on insulin injections. It focuses on combining proprietary cells with a state-of-the-art device to provide a true replacement for the missing beta cells in a diabetic patient without immunosuppression. The company was founded by Robert A. Millman, Walter A. Blättler, Felicia Pagliuca, Jeff Imbaro and Douglas A. Melton in 2015 and is headquartered in Cambridge, MA. | Biotechnology | Director/Board Member Director/Board Member | |
| SANA BIOTECHNOLOGY, INC. | Biotechnology | Director/Board Member Chief Tech/Sci/R&D Officer | |
| MOMENTA PHARMACEUTICALS, INC. | Pharmaceuticals: Major | Director/Board Member Director of Finance/CFO | |
| The Leonard N Stern School of Business | College/University | Masters Business Admin Masters Business Admin | |
| KERYX BIOPHARMACEUTICALS | Pharmaceuticals: Major | Sales & Marketing Human Resources Officer | |
KinDex Pharmaceuticals, Inc.
 KinDex Pharmaceuticals, Inc. BiotechnologyHealth Technology Kindex Pharmaceuticals, Inc. operates as a biopharmaceutical company. It focuses on discovering and developing of novel therapeutics for the treatment of metabolic. The company is headquartered in Boston, MA. | Biotechnology | Director/Board Member Chief Executive Officer | |
| Ithaca College | College/University | Undergraduate Degree Undergraduate Degree | |
| PULMATRIX, INC. | Pharmaceuticals: Major | Director/Board Member Chairman | |
Wellington Management Co. LLP
 Wellington Management Co. LLP Investment ManagersFinance Wellington Management Co. LLP (WMC) is a registered investment advisor and mutual fund manager headquartered in Boston, Massachusetts. The firm was founded in 1928 and is a subsidiary of Wellington Investment Advisors Holdings LLP, ultimately held by Wellington Management Group LLP. WMC offers investment management services for a fee to separate account clients and mutual funds sponsored by unaffiliated parties, as well as to investment vehicles that the firm sponsors. | Investment Managers | Analyst-Equity Comptroller/Controller/Auditor | |
| AC IMMUNE SA | Pharmaceuticals: Major | Chairman Director/Board Member | |
| SHIRE | Pharmaceuticals: Major | Director/Board Member Public Communications Contact | |
| VOYAGER THERAPEUTICS, INC. | Biotechnology | Corporate Officer/Principal Chairman | |
Immunex Corp.
 Immunex Corp. BiotechnologyHealth Technology Immunex Corporation is a leading biopharmaceutical company dedicated to improving lives through immune system science innovation | Biotechnology | Chief Executive Officer Chief Tech/Sci/R&D Officer | |
| AMGEN INC. | Pharmaceuticals: Major | Corporate Officer/Principal Sales & Marketing |
Statistiche
Distribuzione geografica
| Stati Uniti | 47 |
| Nuova-Zelanda | 2 |
| Giappone | 2 |
| Svizzera | 2 |
| Irlanda | 2 |
Settori
| Health Technology | 35 |
| Consumer Services | 11 |
| Finance | 5 |
| Commercial Services | 2 |
| Health Services | 2 |
Posizioni
| Director/Board Member | 256 |
| Corporate Officer/Principal | 107 |
| Independent Dir/Board Member | 72 |
| Undergraduate Degree | 50 |
| Chairman | 42 |
Contatti più connessi
| Insiders | |
|---|---|
| Steven Gillis | 58 |
| Stephen Knight | 39 |
| David Evans Shaw | 30 |
| Mitchell Finer | 26 |
| Julie McHugh | 26 |
| Douglas Williams | 25 |
| Robert Tepper | 24 |
| Ricky Sun | 24 |
| George Conrades | 23 |
| Michael Higgins | 20 |
| Halley Gilbert | 17 |
| Christopher T. Walsh | 17 |
| Gina Consylman | 14 |
| Abraham Ceesay | 13 |
| Marsha Fanucci | 13 |
- Borsa valori
- Insiders
- James M. DeTore
- Connessioni Società
